BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Olbei M, Hautefort I, Modos D, Treveil A, Poletti M, Gul L, Shannon-Lowe CD, Korcsmaros T. SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients. Front Immunol 2021;12:629193. [PMID: 33732251 DOI: 10.3389/fimmu.2021.629193] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 9.0] [Reference Citation Analysis]
Number Citing Articles
1 Poletti M, Treveil A, Csabai L, Gul L, Modos D, Madgwick M, Olbei M, Bohar B, Valdeolivas A, Turei D, Verstockt B, Triana S, Alexandrov T, Saez-rodriguez J, Stanifer ML, Boulant S, Korcsmaros T. Mapping the epithelial–immune cell interactome upon infection in the gut and the upper airways. npj Syst Biol Appl 2022;8. [DOI: 10.1038/s41540-022-00224-x] [Reference Citation Analysis]
2 Cenci A, Macchia I, La Sorsa V, Sbarigia C, Di Donna V, Pietraforte D. Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2. Front Microbiol 2022;13:871645. [DOI: 10.3389/fmicb.2022.871645] [Reference Citation Analysis]
3 Cervantes-Díaz R, Sosa-Hernández VA, Torres-Ruíz J, Romero-Ramírez S, Cañez-Hernández M, Pérez-Fragoso A, Páez-Franco JC, Meza-Sánchez DE, Pescador-Rojas M, Sosa-Hernández VA, Gómez-Martín D, Maravillas-Montero JL. Severity of SARS-CoV-2 infection is linked to double-negative (CD27- IgD-) B cell subset numbers. Inflamm Res 2021. [PMID: 34850243 DOI: 10.1007/s00011-021-01525-3] [Reference Citation Analysis]
4 Olbei M, Thomas JP, Hautefort I, Treveil A, Bohar B, Madgwick M, Gul L, Csabai L, Modos D, Korcsmaros T. CytokineLink: A Cytokine Communication Map to Analyse Immune Responses-Case Studies in Inflammatory Bowel Disease and COVID-19. Cells 2021;10:2242. [PMID: 34571891 DOI: 10.3390/cells10092242] [Reference Citation Analysis]
5 Golota AS, Kamilova TA, Shneider OV, Vologzhanin DA, Sherbak SG. Pathogenesis of the initial stages of severe COVID-19. Journal of Clinical Practice 2021;12:83-102. [DOI: 10.17816/clinpract71351] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Astapenko D, Tomasova A, Ticha A, Hyspler R, Chua HS, Manzoor M, Skulec R, Lehmann C, Hahn R, Malbrain ML, Cerny V. Endothelial glycocalyx damage in patients with severe COVID-19 on mechanical ventilation - a prospective observational pilot study. Clin Hemorheol Microcirc 2022. [PMID: 35342082 DOI: 10.3233/CH-221401] [Reference Citation Analysis]
7 Dada LA, Vagin O, Sznajder JI. Dysregulation of ion transport in the lung epithelium infected with SARS-CoV-2. Am J Physiol Lung Cell Mol Physiol 2021;320:L1183-5. [PMID: 33881360 DOI: 10.1152/ajplung.00170.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ling L, Chen Z, Lui G, Wong CK, Wong WT, Ng RWY, Tso EYK, Fung KSC, Chan V, Yeung ACM, Hui DSC, Chan PKS. Longitudinal Cytokine Profile in Patients With Mild to Critical COVID-19. Front Immunol 2021;12:763292. [PMID: 34938289 DOI: 10.3389/fimmu.2021.763292] [Reference Citation Analysis]
9 Barzin Tond S, Balenci L, Khajavirad N, Salehi M, Tafakhori A, Shahmohammadi MR, Ghiasvand F, Jafari S, Abolghasemi S, Mokhtari F, Mahmoodi Baram S, Zarei T, Kazemi D, Mohammadnejad E, Shah-Hosseini A, Haghbin Toutounchi A, Fallah S, Riazi A, Karima S. Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial. Inflammopharmacology 2022. [PMID: 35201518 DOI: 10.1007/s10787-022-00928-w] [Reference Citation Analysis]
10 Schoeman D, Fielding BC. Human Coronaviruses: Counteracting the Damage by Storm. Viruses 2021;13:1457. [PMID: 34452323 DOI: 10.3390/v13081457] [Reference Citation Analysis]
11 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
12 Kumar A, Narayan RK, Prasoon P, Kumari C, Kaur G, Kumar S, Kulandhasamy M, Sesham K, Pareek V, Faiq MA, Pandey SN, Singh HN, Kant K, Shekhawat PS, Raza K, Kumar S. COVID-19 Mechanisms in the Human Body-What We Know So Far. Front Immunol 2021;12:693938. [PMID: 34790191 DOI: 10.3389/fimmu.2021.693938] [Reference Citation Analysis]
13 Cannon RD. Oral Fungal Infections: Past, Present, and Future. Front Oral Health 2022;3:838639. [DOI: 10.3389/froh.2022.838639] [Reference Citation Analysis]
14 Kaivola J, Nyman TA, Matikainen S. Inflammasomes and SARS-CoV-2 Infection. Viruses 2021;13:2513. [PMID: 34960782 DOI: 10.3390/v13122513] [Reference Citation Analysis]
15 Saratale GD, Shin H, Shinde SK, Kim D, Saratale RG, Kadam AA, Kumar M, Bahkali AH, Syed A, Ghodake GS. Significance of Immune Status of SARS-CoV-2 Infected Patients in Determining the Efficacy of Therapeutic Interventions. JPM 2022;12:349. [DOI: 10.3390/jpm12030349] [Reference Citation Analysis]
16 Clough E, Chean KT, Inigo J, Tubbesing KE, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J Neuroimmune Pharmacol 2021. [PMID: 34599743 DOI: 10.1007/s11481-021-10015-6] [Reference Citation Analysis]
17 Burslem R, Gottesman K, Newkirk M, Ziegler J. Energy requirements for critically ill patients with COVID-19. Nutr Clin Pract 2022. [PMID: 35315122 DOI: 10.1002/ncp.10852] [Reference Citation Analysis]
18 Abid A, Khan MA, Lee B, White A, Carnt N, Arshad S, Samarawickrama C, Anand V. Ocular Distribution of the Renin-Angiotensin-Aldosterone System in the Context of the SARS-CoV-2 Pandemic. Journal of the Renin-Angiotensin-Aldosterone System 2022;2022:1-9. [DOI: 10.1155/2022/9970922] [Reference Citation Analysis]
19 Paull JRA, Luscombe CA, Castellarnau A, Heery GP, Bobardt MD, Gallay PA. Protective Effects of Astodrimer Sodium 1% Nasal Spray Formulation against SARS-CoV-2 Nasal Challenge in K18-hACE2 Mice. Viruses 2021;13:1656. [PMID: 34452519 DOI: 10.3390/v13081656] [Reference Citation Analysis]
20 Ganesh GV, Mohanram RK. Metabolic reprogramming and immune regulation in viral diseases. Rev Med Virol 2021;:e2268. [PMID: 34176174 DOI: 10.1002/rmv.2268] [Reference Citation Analysis]
21 Sotomayor-lugo F, Alemañy-díaz Perera C, Roblejo-balbuena H, Zúñiga-rosales Y, Monzón-benítez G, Suárez-besil B, González-torres MDLÁ, Torres-rives B, Álvarez-gavilán Y, Bravo-ramírez M, Pereira-roche N, Benítez-cordero Y, Silva-ayçaguer LC, Marcheco-teruel B. The role of tumor necrosis factor alpha − 308A > G polymorphism on the clinical states of SARS-CoV-2 infection. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00274-0] [Reference Citation Analysis]
22 Beddok A, Chevrier M, Calugaru V, Minsat M, Dendale R, Lantz O, Servois V, Paoletti X, Crehange G. Acute and late toxicities of patients infected with SARS-CoV-2 and treated for cancer with radiation therapy during the COVID-19 pandemic. Int J Radiat Biol 2021;:1-5. [PMID: 34269644 DOI: 10.1080/09553002.2021.1956008] [Reference Citation Analysis]
23 Rabiu Abubakar A, Ahmad R, Rowaiye AB, Rahman S, Iskandar K, Dutta S, Oli AN, Dhingra S, Tor MA, Etando A, Kumar S, Irfan M, Gowere M, Chowdhury K, Akter F, Jahan D, Schellack N, Haque M. Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm. Life 2022;12:478. [DOI: 10.3390/life12040478] [Reference Citation Analysis]